NasdaqCM - Nasdaq Real Time Price USD

Aadi Bioscience, Inc. (AADI)

1.9201

+0.0401

(+2.13%)

As of 11:59 AM EDT. Market Open.

Key Events

Loading Chart for AADI

9/21 12:03 PM

DELL

Previous Close 1.8800
Open 1.9300
Bid 1.8800 x 400
Ask 1.9300 x 200
Day's Range 1.8800 - 1.9300
52 Week Range 1.5500 - 8.6000
Volume 33,247
Avg. Volume 343,208
Market Cap (intraday) 47.147M
Beta (5Y Monthly) 0.35
PE Ratio (TTM) --
EPS (TTM) -2.5500
Earnings Date Aug 7, 2024 - Aug 12, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 11.00

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.

75

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AADI

4.95%

S&P 500

10.95%

1-Year Return

AADI

72.37%

S&P 500

28.32%

3-Year Return

AADI

88.96%

S&P 500

26.79%

5-Year Return

AADI

87.69%

S&P 500

86.71%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Aadi Bioscience, Inc.

1.9201

+2.13%

Mkt Cap 47.147M

Industry Biotechnology

AN2 Therapeutics, Inc.

2.2700

-1.73%

Mkt Cap 68.885M

Industry Biotechnology

PMV Pharmaceuticals, Inc.

2.1850

+2.10%

Mkt Cap 112.404M

Industry Biotechnology

XTL Biopharmaceuticals Ltd.

2.7600

+3.37%

Mkt Cap 15.852M

Industry Biotechnology

Repare Therapeutics Inc.

3.5700

-3.25%

Mkt Cap 151.941M

Industry Biotechnology

Spruce Biosciences, Inc.

0.8001

-2.99%

Mkt Cap 32.926M

Industry Biotechnology

2.9050

+11.30%

Mkt Cap 141.355M

Industry Biotechnology

Achilles Therapeutics plc

0.9203

+0.03%

Mkt Cap 38.011M

Industry Biotechnology

Bolt Biotherapeutics, Inc.

0.8851

-32.95%

Mkt Cap 34.003M

Industry Biotechnology

Cyclacel Pharmaceuticals, Inc.

2.3600

-16.90%

Mkt Cap 3.453M

Industry Biotechnology

Molecular Templates, Inc.

1.4300

-4.03%

Mkt Cap 9.415M

Industry Biotechnology

Valuation Measures

As of 5/14/2024

Market Cap

46.16M
Enterprise Value

-40.95M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

2.13
Price/Book (mrq)

0.51
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-288.72%
Return on Assets (ttm)

-33.11%
Return on Equity (ttm)

-58.22%
Revenue (ttm)

23.84M
Net Income Avi to Common (ttm)

-68.83M
Diluted EPS (ttm)

-2.5500

Balance Sheet and Cash Flow

Total Cash (mrq)

88.27M
Total Debt/Equity (mrq)

1.29%
Levered Free Cash Flow (ttm)

-35.58M

AADI does not have Company Insights

ABOS Acumen Pharmaceuticals, Inc.

3.8300

+3.79%

PMVP PMV Pharmaceuticals, Inc.

2.1850

+2.10%

TYRA Tyra Biosciences, Inc.

18.54

-0.24%

IMRX Immuneering Corporation

1.5700

-1.87%

RPHM Reneo Pharmaceuticals, Inc.

1.6201

+0.01%

VTYX Ventyx Biosciences, Inc.

4.2600

+2.16%

BCAB BioAtla, Inc.

2.9050

+11.30%

VINC Vincerx Pharma, Inc.

0.7693

+0.65%

XLO Xilio Therapeutics, Inc.

1.1500

+5.61%

GBIO Generation Bio Co.

4.0900

+15.54%

TNGX Tango Therapeutics, Inc.

7.79

+2.50%

LBPH Longboard Pharmaceuticals, Inc.

20.87

+2.56%

TNYA Tenaya Therapeutics, Inc.

4.4900

+2.05%

FDMT 4D Molecular Therapeutics, Inc.

25.76

+0.04%

LVTX LAVA Therapeutics N.V.

2.9200

+1.04%

GLUE Monte Rosa Therapeutics, Inc.

5.36

+7.07%